All In Biotech

Free tool

FAERS Monitor: Methotrexate Sodium

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 008085 or its brand name (Methotrexate Sodium, Methotrexate Sodium). Reports on generic versions are filed under their own applications.

Reports

76,327

Serious

47,719

63% of reports

Hospitalization

16,168

Death reported

4,446

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective19,726
  • drug hypersensitivity7,824
  • off label use6,466
  • rheumatoid arthritis5,720
  • drug intolerance5,635
  • nausea5,389
  • arthralgia5,078
  • pain5,067
  • condition aggravated4,721
  • fatigue4,529
  • joint swelling3,552
  • treatment failure3,321
  • alopecia3,254
  • rash3,246
  • diarrhoea2,829

Reports by year received

View as table
YearReports
2004767
2005506
2006181
2007249
2008267
2009263
2010161
2011385
2012682
2013772
2014513
20151,132
20164,126
201710,226
201812,491
20199,172
20206,834
20214,865
20226,005
20235,993
20245,136
20253,824
20261,777

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,832 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal5,63517.016.680,302
rheumatoid arthritisSignal5,72014.614.268,995
drug hypersensitivitySignal7,82411.611.373,147
treatment failureSignal3,32111.511.130,565
joint swellingSignal3,5528.38.122,338
alopeciaSignal3,2544.64.59,177
condition aggravatedSignal4,7214.34.212,076
drug ineffectiveSignal19,7264.24.149,990
arthralgiaSignal5,0783.43.38,642
painSignal5,0672.32.23,734
rashSignal3,2462.12.01,793
off label useSignal6,4662.02.03,563
nausea5,3891.91.82,299
fatigue4,5291.61.61,070
diarrhoea2,8291.21.2104

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.